ABSTRACT

There are several etiological factors that contribute to CVD, including atrial fibrillation, which causes rheumatic fever and ischemic stroke. These diseases are typically caused by the formation of emboli. Another important factor is atherosclerosis, which is a major cause of CVD. The main objective of the present work is to assess the prescribing patterns of anti- platelets and anti- coagulants in cardiovascular diseases and to determine the quality of life. The study is a prospective observational study conducted in the Department of Cardiology for a period of 6 months. 100-200 patients are supposed to be studied over a period of 6 months according to appropriate parameters and procedure. An informed consent form in a written format was taken from the patient to collect a data. Total 260 subjects were included in our study. Among them 69.24% were males and 30.76% were females. In our study percentage of urban people were 71.54% known with CVDs appears to be more in number than rural people (28.46%). Our study has relatively high number of patients of age group above 50 (32.2%) and the age group above 60 also had a significant percent of 31.5%. The anti-platelets and anti- coagulants were prescribed based on the risk of the patients. If the patient is at higher risk, then there is combination of therapy whether it is dual therapy or triple therapy. The people who are with lower risk, then single anti-platelet or anti-coagulant therapy. Sometimes the antiplatelets are prescribed with the combination of statins. The quality of life is poor in people who are suffering with co-morbid conditions like vascular diseases, expand all the four domain that are present in our questionnaire. Keywords: Anti-platelets, anti-coagulants, cardiovascular diseases, anti-anginal drugs, beta- blockers
Publication date: 01/05/2026

https://www.ijbpas.com/pdf/2026/May/MS_IJBPAS_2026_10217.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2026/15.5.10217